p57 Kip2 antibody | knockout validation | Santa Cruz sc-56341

This is a knockout-validated antibody summary, based on the publication "Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

p57 Kip2 antibody | knockout validation | Santa Cruz sc-56341 figure 1
Figure 1. Representative immunofluorescence images showing expression and localisation of GR (green), p57 (red) in p57-WT and p57-KO cell lines. DAPI is used as nuclear staining (blue) (n = 3). Scale bar, 10 μm. From [1].
Antibody information

Mouse monoclonal IgG2b κ

Company: Santa Cruz

Antibody: p57 Kip2

Catalog number: sc-56341

Summary: Mouse monoclonal antibody against full length human p57 Kip2. Recommended for detection of p57 Kip2 of mouse, rat and human origin by western blot, immunoprecipitation, immunofluorescence, immunohistochemistry (paraffin) and ELISA.

Validation Method

Immunocytochemistry

Sample

p57-WT and p57-KO A549, H2122 and H1944 cell lines.

Blocking agent

1% BSA in PBS for 60 min.

Primary incubation

1:50 dilution for 2 h at room temperature.

Secondary incubation

1:1,000 dilution goat anti-Mouse IgG (H + L) Cross-Adsorbed Secondary Antibody, Alexa Fluor 488 (A11001, Thermo Fisher Scientific).

Detection

Laser confocal microscopy (SP5, Leica).

Clone note

The same clone (KP39) is sold as Santa Cruz Biotechnology sc-56341; LifeSpan Biosciences LS-C88548, LS-C88549, LS-B8635; Invitrogen MA5-14361.

References
  1. Prekovic S, Schuurman K, Mayayo Peralta I, Manjón A, Buijs M, Yavuz S, et al. Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer. Nat Commun. 2021;12:4360 pubmed publisher